2023
DOI: 10.1007/s00018-023-04866-w
|View full text |Cite
|
Sign up to set email alerts
|

Kindlin-2 controls angiogenesis through modulating Notch1 signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 61 publications
1
1
0
Order By: Relevance
“…Immunohistochemical (IHC) staining of α-SMA and CD31 (biomarker of angiogenesis) was performed to assess the level of a newly formed blood vessel. 36 Consistently, the highest expressions of α-SMA (Figure 6e,f) and CD31 (Figure S19) arose from the VEGF@Gel EFM treatment group, while Gel EFM itself induces a moderate increase in α-SMA and CD31 expression. The in vivo ROS-scavenging efficacy of the hydrogels was also assessed using IHC staining for the proinflammatory cytokines IL-6 and IL-1β.…”
Section: Diabetic Wound Healing In Vivosupporting
confidence: 55%
See 1 more Smart Citation
“…Immunohistochemical (IHC) staining of α-SMA and CD31 (biomarker of angiogenesis) was performed to assess the level of a newly formed blood vessel. 36 Consistently, the highest expressions of α-SMA (Figure 6e,f) and CD31 (Figure S19) arose from the VEGF@Gel EFM treatment group, while Gel EFM itself induces a moderate increase in α-SMA and CD31 expression. The in vivo ROS-scavenging efficacy of the hydrogels was also assessed using IHC staining for the proinflammatory cytokines IL-6 and IL-1β.…”
Section: Diabetic Wound Healing In Vivosupporting
confidence: 55%
“…In addition, the VEGF@Gel EFM -treated group also exhibited the highest degree in collagen deposition (45.58%, P < 0.001), as revealed by Masson staining (Figure c,d). Immunohistochemical (IHC) staining of α-SMA and CD31 (biomarker of angiogenesis) was performed to assess the level of a newly formed blood vessel . Consistently, the highest expressions of α-SMA (Figure e,f) and CD31 (Figure S19) arose from the VEGF@Gel EFM treatment group, while Gel EFM itself induces a moderate increase in α-SMA and CD31 expression.…”
Section: Resultsmentioning
confidence: 99%